Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 7/20 | 0.50 |
| ▸ | MAOB | P27338 | 7/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 1/20 | 0.39 |
| ▸ | RXRG | P48443 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23810763 | 0.94 | MAOA (0.56) | MAOAMAOBKDM4ELMNAPOLB | |
| Trifluoroacetic Acid SCHEMBL23320781 | 0.83 | ALOX15 (0.51) | MAOAMAOBKDM4EHRH3RXRA | |
| SCHEMBL3875255 | 0.80 | MAOA (0.68) | MAOAMAOBHRH3 | |
| Hydrochloric Acid SCHEMBL3902331 | 0.79 | MAOA (0.66) | MAOAMAOBHRH3 | |
| SCHEMBL23320783 | 0.79 | HRH3 (0.44) | MAOAMAOBKDM4EHRH3RXRA | |
| SCHEMBL6489929 | 0.75 | HRH3 (0.48) | MAOAMAOBKDM4ELMNAHRH3 | |
| Hydrochloric Acid SCHEMBL3902342 | 0.74 | MAOB (0.59) | MAOAMAOBHRH3 | |
| Trifluoroacetic Acid SCHEMBL3902745 | 0.74 | S1PR1 (0.54) | MAOAMAOBHRH3 | |
| SCHEMBL13598169 | 0.73 | MAOB (0.58) | MAOAMAOBKDM4EHRH3 | |
| SCHEMBL6421129 | 0.73 | MAOA (0.64) | MAOAMAOBHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542273-B2 | Amide compound having bet proteolysis-inducing action and medicinal application thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542273-B2 | Amide compound having bet proteolysis-inducing action and medicinal application thereof | BET1, BRD4, PHKB | MAOA 4398/4885MAOB 4471/4885KDM4E 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.